Article
The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer
2019-11-06
Abstract excerpt
<h4>ABSTRACT</h4> <h4>BACKGROUND</h4> After long-term androgen deprivation therapy, 25-30% prostate cancer (PCa) acquires an aggressive neuroendocrine (NE) phenotype. Dysregulation of YAP1, a key transcription coactivator of the Hippo pathway, has been related to cancer progression. However, its role in neuroendocrine prostate cancer (NEPC) has not been assessed. <h4>METHODS</h4> Immunohistochemistry was used t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c16fa5f6-8086-58f6-8b42-233732c20bf5
- DOI
- 10.1101/832360
